The modulators of the genital system and sex hormones market in Finland experienced fluctuating values between 2013 and 2023. The market peaked in 2014 at $76.7 million but declined overall, reaching $59.8 million in 2023. The most significant year-on-year variations occurred in 2015 (-15.51%) and 2021 (-8.18%). From 2018 onwards, the market showed a trend of gradual decline with minor fluctuations, having a CAGR of -1.75% from 2018 to 2022, and -2.62% from 2019 to 2023. Forecasts indicate a slight uptick with a 0.13% CAGR projected from 2024 to 2028, anticipating a minor growth rate of 0.67%.
Future trends to watch for:
- Regulatory changes affecting hormone therapies
- Technological advancements in drug delivery systems
- Increasing awareness and diagnosis of related health conditions
- Potential impact of an aging population on demand
